Matthew R. Plooster

Chairman at KemPharm

Mr. Plooster has served as a director of KemPharm since March 2011 and as KemPharm’s chairman of the Board of Directors since January 2023. Mr. Plooster co-founded Bridgepoint Investment Banking, a division of Bridgepoint Holdings, LLC and Bridgepoint Holdings NE, LLC, where he has served as Managing Director since March 2012. Previously, Mr. Plooster worked as an investment banker at DeWaay Investment Banking from October 2010 to March 2012, Morgan Stanley from August 2009 to November 2009 and Deutsche Bank from 2004 to July 2009. Mr. Plooster received his Certificate in Business Excellence from Columbia Business School and his B.A. degree from the University of Chicago.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


KemPharm

KemPharm, Inc. is a clinical-stage specialty pharmaceutical company. The Company is engaged in the discovery and development of prodrugs. The Company uses its Ligand Activated Therapy (LAT) platform technology to create prodrugs. The Company's product ...


Industries

Employees

11-50

Links